These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33000194)

  • 1. Effects of PEG anchors in PEGylated siRNA lipoplexes on in vitro gene‑silencing effects and siRNA biodistribution in mice.
    Hattori Y; Tamaki K; Sakasai S; Ozaki KI; Onishi H
    Mol Med Rep; 2020 Nov; 22(5):4183-4196. PubMed ID: 33000194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
    Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
    J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
    Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
    J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pre‑freezing and saccharide types in freeze‑drying of siRNA lipoplexes on gene‑silencing effects in the cells by reverse transfection.
    Tang M; Hu S; Hattori Y
    Mol Med Rep; 2020 Oct; 22(4):3233-3244. PubMed ID: 32945442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of PEG anchor in PEGylation of folate-modified cationic liposomes with PEG-derivatives on systemic siRNA delivery into the Tumor.
    Tang M; Sakasai S; Onishi H; Kawano K; Hattori Y
    J Drug Target; 2023 Jan; 31(1):74-88. PubMed ID: 35864749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cationic lipid in cationic liposomes on siRNA delivery into the lung by intravenous injection of cationic lipoplex.
    Hattori Y; Nakamura M; Takeuchi N; Tamaki K; Shimizu S; Yoshiike Y; Taguchi M; Ohno H; Ozaki KI; Onishi H
    J Drug Target; 2019 Feb; 27(2):217-227. PubMed ID: 30024300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEGylation of lipoplexes: The right balance between cytotoxicity and siRNA effectiveness.
    Lechanteur A; Furst T; Evrard B; Delvenne P; Hubert P; Piel G
    Eur J Pharm Sci; 2016 Oct; 93():493-503. PubMed ID: 27593989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA.
    Li Y; Cheng Q; Jiang Q; Huang Y; Liu H; Zhao Y; Cao W; Ma G; Dai F; Liang X; Liang Z; Zhang X
    J Control Release; 2014 Feb; 176():104-14. PubMed ID: 24365128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sterol derivatives in cationic liposomes on biodistribution and gene-knockdown in the lungs of mice systemically injected with siRNA lipoplexes.
    Hattori Y; Saito H; Oku T; Ozaki KI
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of a Novel PEGylated Liposomal Vector for Systemic Delivery of siRNA to Solid Tumors.
    Song F; Sakurai N; Okamoto A; Koide H; Oku N; Dewa T; Asai T
    Biol Pharm Bull; 2019; 42(6):996-1003. PubMed ID: 31155597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cationic lipids in cationic liposomes and disaccharides in the freeze-drying of siRNA lipoplexes on gene silencing in cells by reverse transfection.
    Hattori Y; Hu S; Onishi H
    J Liposome Res; 2020 Sep; 30(3):235-245. PubMed ID: 31185779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-angiogenic therapy via cationic liposome-mediated systemic siRNA delivery.
    Tagami T; Suzuki T; Matsunaga M; Nakamura K; Moriyoshi N; Ishida T; Kiwada H
    Int J Pharm; 2012 Jan; 422(1-2):280-9. PubMed ID: 22101286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEGylated DC-Chol/DOPE cationic liposomes containing KSP siRNA as a systemic siRNA delivery Carrier for ovarian cancer therapy.
    Lee J; Ahn HJ
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1716-1722. PubMed ID: 30049442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity.
    Belletti D; Tosi G; Forni F; Lagreca I; Barozzi P; Pederzoli F; Vandelli MA; Riva G; Luppi M; Ruozi B
    Eur J Pharm Biopharm; 2016 Feb; 99():7-17. PubMed ID: 26625717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of PEGylated cationic nanoliposome-siRNA complexes for cancer therapy.
    Haghiralsadat F; Amoabediny G; Naderinezhad S; Forouzanfar T; Helder MN; Zandieh-Doulabi B
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):684-692. PubMed ID: 29475393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfection efficacy and drug release depends upon the PEG derivative in cationic lipoplexes: Evaluation in 3D in vitro model and in vivo.
    A M G; O O K; A S N; L I V; V A S; L A K; E A E; V V S; U A B; Yu L S; N E S; M R K; E M
    J Biomed Mater Res B Appl Biomater; 2023 Sep; 111(9):1614-1628. PubMed ID: 37132593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zwitterionic poly(carboxybetaine)-based cationic liposomes for effective delivery of small interfering RNA therapeutics without accelerated blood clearance phenomenon.
    Li Y; Liu R; Shi Y; Zhang Z; Zhang X
    Theranostics; 2015; 5(6):583-96. PubMed ID: 25825598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effect for liver-metastasized tumor by sequential intravenous injection of anionic polymer and cationic lipoplex of siRNA.
    Hattori Y; Arai S; Kikuchi T; Ozaki KI; Kawano K; Yonemochi E
    J Drug Target; 2016 Apr; 24(4):309-317. PubMed ID: 26234899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal combination of cationic lipid and phospholipid in cationic liposomes for gene knockdown in breast cancer cells and mouse lung using siRNA lipoplexes.
    Hattori Y; Tang M; Torii S; Tomita K; Sagawa A; Inoue N; Yamagishi R; Ozaki KI
    Mol Med Rep; 2022 Aug; 26(2):. PubMed ID: 35686555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(vinyl pyrrolidone) derivatives as PEG alternatives for stealth, non-toxic and less immunogenic siRNA-containing lipoplex delivery.
    Berger M; Toussaint F; Djemaa SB; Laloy J; Pendeville H; Evrard B; Jerôme C; Lechanteur A; Mottet D; Debuigne A; Piel G
    J Control Release; 2023 Sep; 361():87-101. PubMed ID: 37482343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.